A Platform for the Generation of Site-Specific Antibody-Drug Conjugates That Allows for Selective Reduction of Engineered Cysteines.

Bioconjugate Chemistry
Ruud G E CoumansC Marco Timmers

Abstract

Engineering cysteines at specific sites in antibodies to create well-defined ADCs for the treatment of cancer is a promising approach to increase the therapeutic index and helps to streamline the manufacturing process. Here, we report the development of an in silico screening procedure to select for optimal sites in an antibody to which a hydrophobic linker-drug can be conjugated. Sites were identified inside the cavity that is naturally present in the Fab part of the antibody. Conjugating a linker-drug to these sites demonstrated the ability of the antibody to shield the hydrophobic character of the linker-drug while resulting ADCs maintained their cytotoxic potency in vitro. Comparison of site-specific ADCs versus randomly conjugated ADCs in an in vivo xenograft model revealed improved efficacy and exposure. We also report a selective reducing agent that is able to reduce the engineered cysteines while leaving the interchain disulfides in the oxidized state. This enables us to manufacture site-specific ADCs without introducing impurities associated with the conventional reduction/oxidation procedure for site-specific conjugation.

References

Jun 5, 2003·Nature Biotechnology·Svetlana O DoroninaPeter D Senter
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin J HamblettJoseph A Francisco
Sep 10, 2005·Nature Biotechnology·Anna M Wu, Peter D Senter
Aug 21, 2007·Accounts of Chemical Research·Ravi V J Chari
Jul 22, 2008·Nature Biotechnology·Jagath R JunutulaWilliam Mallet
May 28, 2010·The Journal of Biological Chemistry·Henry R MaunSarah G Hymowitz
Dec 18, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Amey BandekarStavroula Sofou
Feb 25, 2014·Bioconjugate Chemistry·Yilma T AdemOsigwe Esue
Apr 1, 2015·Journal of Computational Chemistry·Elmar Krieger, Gert Vriend
Aug 1, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ningyan ZhangZhiqiang An
Jan 8, 2017·Molecular Cancer Therapeutics·Patrick J BurkeRobert P Lyon
Jan 26, 2018·Protein Engineering, Design & Selection : PEDS·D SussmanD R Benjamin
Sep 4, 2019·Lancet·Cindy H ChauWilliam D Figg

❮ Previous
Next ❯

Citations

Dec 29, 2020·Bioorganic & Medicinal Chemistry·Jisoo ParkTae Hyeon Yoo
Jan 22, 2021·Bioconjugate Chemistry·Camille M Le GallMartijn Verdoes
Jan 23, 2021·ACS Chemical Biology·Mariha IslamJames A Van Deventer
Oct 2, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M MuraliL R Nath
Nov 3, 2021·Nano Convergence·Jessica A Kemp, Young Jik Kwon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.